Acer Therapeutics Inc (NASDAQ: ACER) announced topline results from its Phase 2a proof of concept clinical trial to evaluate ACER-801 (osanetant) as a potential treatment for...
By Peter Nurse Investing.com - European stock markets traded sharply higher Friday, with sentiment boosted by moves in both Europe and the United States to support under-pressure...
By Peter Nurse Investing.com - European stock markets are expected to open higher Friday, with sentiment boosted by moves in both Europe and the United States to support...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
The Federal Reserve is set to deliver another .75 point interest rate hike tomorrow—and a few more before the end of the year The largest beneficiary in such a scenario is...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
| Average | 105.97 (+17.51% Upside) |
| High | 124.00 |
| Low | 85.00 |
| Price | 90.18 |
| No. of Analysts | 23 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Sell | Buy | Strong Buy | Buy |
| Summary | Strong Sell | Strong Sell | Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 18.74 | 18.85 | 18.38 | +0.60 | +3.31% | 1.84M | Toronto | |||
| 28.81 | 29.12 | 28.64 | +0.23 | +0.80% | 638.59K | Toronto | |||
| 2.28 | 2.33 | 2.20 | -0.1100 | -4.60% | 11.00K | TSXV | |||
| 0.165 | 0.17 | 0.165 | -0.0050 | -2.94% | 168.50K | TSXV | |||
| 1.19 | 1.22 | 1.14 | +0.01 | +0.85% | 2.10K | Toronto | |||
| 0.77 | 0.78 | 0.75 | +0.0100 | +1.32% | 258.82K | TSXV | |||
| 0.215 | 0.22 | 0.205 | -0.0050 | -2.27% | 153.06K | TSXV | |||
| 71.48 | 71.48 | 70.90 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 1.65 | 1.67 | 1.55 | +0.07 | +4.43% | 268.05K | TSXV | |||
| 24.98 | 24.98 | 24.98 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 0.03 | 0.03 | 0.03 | -0.005 | -14.29% | 2.00K | TSXV | |||
| 59.50 | 60.13 | 58.38 | +2.130 | +3.71% | 489.83K | Toronto | |||
| 23.99 | 24.30 | 23.84 | +0.46 | +1.95% | 576.60K | Toronto | |||
| 10.78 | 10.85 | 10.57 | +0.13 | +1.22% | 3.52M | Toronto | |||
| 23.14 | 23.59 | 22.69 | +0.98 | +4.42% | 7.32M | Toronto |